Navigation Links
Hard To Treat Diseases (HTDS) (H1N1) Vaccine Clinical Approval and Production
Date:9/14/2009

conomic and White Collar Crimes. His has offices in Tarpon Springs and St. Petersburg, Florida.

The issuer's shareholders and followers can expect updates on these matters shortly as the Company is adamant to get to the bottom of that topic and has instructed its barrister to vigorously pursue the matter.

Safe Harbor Statement

Information in this filing may contain statements about future expectations, plans, prospects or performance of Hard to Treat Diseases, Inc. that constitute forward-looking statements for purposes of the safe harbor Provision's under the Private Securities Litigation Reform Act of 1995. The words or phrases "can be," "expects," "may affect," "believed," "estimate," "project," and similar words and phrases are intended to identify such forward-looking statements. HTDS Corporation cautions you that any forward-looking information provided by or on behalf of Hard to Treat Diseases, Inc. is not a guarantee of future performance. None of the information in this filing constitutes or is intended as an offer to sell securities or investment advice of any kind. Hard to Treat Diseases, Inc.'s actual results may differ materially from those anticipated in such forward-looking statements as a result of various important factors, some of which are beyond Hard to Treat Diseases, Inc.'s control. In addition to those discussed in Hard to Treat Diseases, Inc.'s press releases, public filings, and statements by Hard to Treat Diseases, Inc.'s management, including, but not limited to, Hard to Treat Diseases, Inc.'s estimate of the sufficiency of its existing capital resources, Hard to Treat Diseases, Inc.'s ability to raise additional capital to fund future operations, HTDS Corporation's ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities and, in identifying contracts which match Hard to Treat Diseases, Inc.'s capability to be awarded contracts. All such forward-look
'/>"/>

SOURCE Hard to Treat Diseases
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine news :

1. Rib-X Pharmaceuticals Receives Award from NIAID to Develop Antibiotic Treatment for Gonorrhea
2. Study Shows Tubal Reversal Surgery is the Best Treatment to Have More Children After a Tubal Ligation
3. Drug Offers Hope Against Tough-to-Treat Hypertension
4. Hard To Treat Diseases (HTDS) MEVAC-A Completes Tender For Bangladesh
5. New Directions in Angioedema: A Focus on Supportive Care and Treatment Options
6. Most Pharmaceutical Companies Receive Poor Grades on HIV/AIDS Drug Development Innovation, According to AIDS Treatment Activist Coalition Report Card
7. The American Legion Appeals to Congress for Compassionate Treatment of Women Veterans
8. Treating Childhood Leukemia With Fewer Side Effects
9. Hard To Treat Diseases (HTDS) Equipment Purchase, and General Update on its Cancer and Anti Aging Projects
10. Closing the Addiction Treatment Gap (CATG) Statement on Annual National Survey on Drug Use and Health Data Released by the Substance Abuse and Mental Health Services Administration (SAMHSA)
11. Video: Edie Falco and Cynthia Nixon Appear in New Stand Up To Cancer(TM) PSAs Designed to Educate Cancer Patients About the Importance Of Lowering Ones Risk of Infection During Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... FL (May 18, 2013) There are significant ... commonly used to diagnose or treat gastrointestinal problems, ... (DDW). , A study by New York ... more objective testing may substantially reduce the cost ... Although GERD is believed to affect nearly 25 ...
(Date:5/18/2013)... City, Utah (PRWEB) May 18, 2013 ... information on insurance agents’ role in Marketplaces ... alternatives to traditional employer sponsored health benefits, is ... contribution and health reimbursement arrangements . ... of Health and Human Services (HHS) recently released ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 After working diligently ... SizeItUp formally announced the integration of the fitment ... Hyundai Genesis is set to stun the automobile market with ... 2012 Hyundai Genesis is marked as the latest entry in ... the vehicles lined up for the year 2013. , ...
(Date:5/18/2013)... Although obesity is associated with an increased ... and esophageal adenocarcinoma, a type of esophageal cancer, is ... reported on Cancer.gov, last reviewed in January 2012, ... as those of normal and healthy weight to develop ... esophageal cancer is not well understood, it is now ...
(Date:5/18/2013)... Show And Go Training, the culmination of Eric Cressey’s study ... all about is getting results in the fastest amount of ... ’s Stan Stevenson, prompting an investigative review. , “ Show ... designed to make you faster, stronger, fitter and trimmer with ... the gym. The training manual and exercise video database are ...
Breaking Medicine News(10 mins):Health News:New research identifies practice changes to improve value and quality of GI procedures 2Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 2Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 3Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 4Health News:Renowned Rim Fitments Provider SizeItUp Launched Database Integrations for the 2012 Hyundai Genesis 2Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 2Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 3Health News:Show And Go Training: Review Examining Eric Cressy's Workout Program Revealed 2
... and Rose Stein Institute for Research on Aging at the ... novel route to improving the symptoms of subsyndromal depression (SSD) ... video games that combine game play with exercise. In a ... improved mood and mental health-related quality of life in older ...
... ... ... , ... , , , , ...
... ... ... ... ...
... ... ... , ... Outlawing Health Insurance Monopolies Would Be Good for Doctors, Patients , ...
... therapy shows encouraging results for patients with locally advanced ... Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ... but aggressive types of cancer. Patients usually present with ... skull base such as eyes, optic nerves, brain. Between ...
... of the condition are higher in U.S. than Canada, ... Higher levels of obesity and inactivity, especially among women, ... States than in Canada, according to a new study. ... 2002-03 data from both countries and found that the ...
Cached Medicine News:Health News:Video games may help combat depression in older adults 2Health News:All Global Launches Physician Panels in Russia and Poland 2Health News:All Global Launches Physician Panels in Russia and Poland 3Health News:URAC Announces Open Public Comment Period for Expanded Independent Review Organization Accreditation 2Health News:URAC Announces Open Public Comment Period for Expanded Independent Review Organization Accreditation 3Health News:URAC Announces Open Public Comment Period for Expanded Independent Review Organization Accreditation 4Health News:URAC Announces Open Public Comment Period for Expanded Independent Review Organization Accreditation 5Health News:URAC Announces Open Public Comment Period for Expanded Independent Review Organization Accreditation 6Health News:Doctors Applaud House Vote to Remove Anti-Trust Exemption for Health Insurers 2Health News:Doctors Applaud House Vote to Remove Anti-Trust Exemption for Health Insurers 3
(Date:5/17/2013)... -- Atossa Genetics, Inc. (NASDAQ: ATOS ), The Breast ... , Chief Financial Officer & General Counsel, will present at ... 30, 2013, in New York City ... presentation is scheduled to begin at 3:30 p.m. EDT and ... webcast, go to www.atossagenetics.com . For more ...
(Date:5/17/2013)... 17, 2013  Boston Scientific Corporation (NYSE: ... EuroPCR Scientific Program May 21-24 in Paris ... a particularly rich and diversified set of data this ... , M.D., global chief medical officer, Boston Scientific.  "The ... including the NG PROMUS trial, which evaluated our Promus ...
(Date:5/16/2013)... 2013  Nektar Therapeutics, (Nasdaq: NKTR ) President ... , is scheduled to present at the upcoming 2013 UBS ... at the Sheraton New York Hotel on Tuesday, May 21, ... will be accessible via a Webcast through a link posted ... website: http://www.nektar.com . This Webcast will be available for ...
Breaking Medicine Technology:Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2
... -- Global Pharm Holdings Group, Inc. (OTCBB: GPHG.OB) ... vertically integrated pharmaceutical company engaged in pharmaceutical related ... subsidiaries in the Anhui, Jilin, and Shandong provinces, ... first quarter ended March 31, 2011. ...
... Diagnostics, a leading developer of quantitative pulmonary imaging software, ... for the evaluation of pulmonary disease including chronic obstructive ... the 2011 International Conference of the American Thoracic Society ... been installed at leading pulmonary centers for validation and ...
Cached Medicine Technology:Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 2Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 3Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 4Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 5Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 6Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 7Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 8Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 9Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 10Global Pharm Holdings Group Announces First Quarter 2011 Financial Results 11VIDA Diagnostics Launches Apollo Pulmonary Analysis Software for Major Lung Disease at American Thoracic Society Meeting 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: